Home » Stocks » STAA

STAAR Surgical Company (STAA)

Stock Price: $147.01 USD 2.78 (1.93%)
Updated Jun 11, 2021 4:00 PM EDT - Market closed
After-hours: $147.78 +0.77 (0.52%) Jun 11, 4:41 PM
Market Cap 6.89B
Revenue (ttm) 179.03M
Net Income (ttm) 11.04M
Shares Out 46.62M
EPS (ttm) 0.22
PE Ratio 665.20
Forward PE 526.32
Dividend n/a
Dividend Yield n/a
Trading Day June 11
Last Price $147.01
Previous Close $144.23
Change ($) 2.78
Change (%) 1.93%
Day's Open 145.09
Day's Range 142.02 - 147.37
Day's Volume 267,360
52-Week Range 41.98 - 150.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

He'd appreciate its margins and its moat.

1 week ago - The Motley Fool

Staar Surgical (STAA) delivered earnings and revenue surprises of 900.00% and 16.67%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today report...

1 month ago - Business Wire

Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

If you wear contact lenses or eyeglasses, you're in STARR's target market.

1 month ago - The Motley Fool

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announ...

1 month ago - Business Wire

Here's why it's not too late to go long on this eye surgery lens firm.

2 months ago - The Motley Fool

You probably haven't heard of these companies, but they're winners.

Other stocks mentioned: ALGN, MOH
2 months ago - The Motley Fool

I've been waiting to buy these stocks at a better price. Now might just be the time.

Other stocks mentioned: ABMD, TDOC
2 months ago - The Motley Fool

These companies are perfect for investors with a long time horizon.

Other stocks mentioned: JNJ
2 months ago - The Motley Fool

No news is good news for this healthcare company.

3 months ago - The Motley Fool

Staar Surgical (STAA) delivered earnings and revenue surprises of 55.56% and 1.32%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Shares of Staar Surgical (NASDAQ:STAA) moved lower in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 16.67% over the past year to $0.14, which...

3 months ago - Benzinga

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today report...

3 months ago - Business Wire

There isn't much for long-term investors to worry about.

3 months ago - The Motley Fool

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announ...

4 months ago - Business Wire

Both companies are set to join new market indexes.

4 months ago - The Motley Fool

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announ...

4 months ago - Business Wire

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provid...

5 months ago - Business Wire

Despite MedTech industry's bright prospects in 2021, investors should be wary of stocks like BLFS, STAA and TGTX, given their unfavorable Zacks Rank and weak fundamentals.

Other stocks mentioned: BLFS, TGTX
5 months ago - Zacks Investment Research

STAAR Surgical manufactures and sells implantable collamer lenses (ICLs) for patients suffering from myopia or presbyopia. The company only makes ~3.5% in the US market and its largest market shares are...

6 months ago - Seeking Alpha

Staar Surgical (STAA) delivered earnings and revenue surprises of 55.56% and 8.48%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announ...

7 months ago - Business Wire

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today report...

7 months ago - Business Wire

Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

7 months ago - Zacks Investment Research

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announ...

7 months ago - Business Wire

New York, New York--(Newsfile Corp. - October 19, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of S...

7 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - October 19, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of STAAR Surgical Company (NASDAQ: STAA) between Februar...

7 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - October 19, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against STAAR Surgical C...

7 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - October 18, 2020) - Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating claims against STAAR Surgical ...

7 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - October 18, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against STAAR Surgical C...

7 months ago - Newsfile Corp

NEW YORK, Oct. 17, 2020 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA) and certain of its off...

7 months ago - PRNewsWire

New York, New York--(Newsfile Corp. - October 16, 2020) -  Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating claims against STAAR Surgical...

7 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - October 16, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against STAAR Surgical C...

7 months ago - Newsfile Corp

LOS ANGELES--(BUSINESS WIRE)---- $STAA #classaction--The Law Offices of Frank R. Cruz reminds investors of the upcoming October 19, 2020 deadline to file a lead plaintiff motion in the class action file...

7 months ago - Business Wire

Los Angeles, California--(Newsfile Corp. - October 15, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against STAAR Surgical ...

7 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - October 15, 2020) - Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of STAAR Surgical Company (NASDAQ: STAA) between Februar...

7 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - October 14, 2020) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against STAAR Surgical Company ("STAAR" or the ...

7 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - October 14, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against STAAR Surgical C...

7 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - October 13, 2020) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Staar Surgical Company (NASDAQ: STAA) all...

8 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - October 13, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against STAAR Surgical C...

8 months ago - Newsfile Corp

Los Angeles, California--(Newsfile Corp. - October 12, 2020) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against STAAR Surgical C...

8 months ago - Newsfile Corp

San Francisco, California--(Newsfile Corp. - October 11, 2020) - Hagens Berman urges STAAR Surgical Company (NASDAQ: STAA) investors to contact the firm now. A securities fraud class action has been fil...

8 months ago - Newsfile Corp

San Francisco, California--(Newsfile Corp. - October 10, 2020) - Hagens Berman urges STAAR Surgical Company (NASDAQ: STAA) investors to contact the firm now. A securities fraud class action has been fil...

8 months ago - Newsfile Corp

New York, New York--(Newsfile Corp. - October 9, 2020) -  Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating claims against STAAR Surgical ...

8 months ago - Newsfile Corp

NEW YORK, Oct. 9, 2020 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of STAAR Surgical Company (NASDAQ: STAA) between February 26, 2020 and Augu...

8 months ago - PRNewsWire

New York, New York--(Newsfile Corp. - October 8, 2020) - Faruqi & Faruqi, LLP, a leading minority and certified woman-owned national securities law firm, is investigating claims against STAAR Surgical C...

8 months ago - Newsfile Corp

San Francisco, California--(Newsfile Corp. - October 8, 2020) - Hagens Berman urges STAAR Surgical Company (NASDAQ: STAA) investors to contact the firm now. A securities fraud class action has been file...

8 months ago - Newsfile Corp

San Francisco, California--(Newsfile Corp. - October 7, 2020) -  Hagens Berman urges STAAR Surgical Company (NASDAQ: STAA) investors to contact the firm now. A securities fraud class action has been fil...

8 months ago - Newsfile Corp

LOS ANGELES, Oct. 7, 2020 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming October 19, 2020 deadline to file a lead plaintiff motion in the class action filed on beh...

8 months ago - PRNewsWire

About STAA

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the comp... [Read more...]

Industry
Medical Instruments & Supplies
Founded
1982
CEO
Caren Mason
Employees
575
Stock Exchange
NASDAQ
Ticker Symbol
STAA
Full Company Profile

Financial Performance

In 2020, STAAR Surgical's revenue was $163.46 million, an increase of 8.84% compared to the previous year's $150.19 million. Earnings were $5.91 million, a decrease of -57.91%.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for STAAR Surgical stock is "Buy." The 12-month stock price forecast is 138.00, which is a decrease of -6.13% from the latest price.

Price Target
$138.00
(-6.13% downside)
Analyst Consensus: Buy